naringenin has been researched along with Atherosclerotic Parkinsonism in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sekar, S; Sevanan, M; Sugumar, M | 1 |
Ambasta, RK; Anand, K; Kumar, P; Sarkar, A; Sonia Angeline, M | 1 |
2 other study(ies) available for naringenin and Atherosclerotic Parkinsonism
Article | Year |
---|---|
Neuroprotective effect of naringenin against MPTP-induced oxidative stress.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Catalase; Corpus Striatum; Dose-Response Relationship, Drug; Flavanones; Glutathione Reductase; Lipid Peroxidation; Male; Mice; Neuroprotective Agents; Nitric Oxide Synthase Type II; Oxidative Stress; Parkinson Disease, Secondary; Substantia Nigra | 2019 |
Sesamol and naringenin reverse the effect of rotenone-induced PD rat model.
Topics: Animals; Benzodioxoles; Disease Models, Animal; Flavanones; Male; Parkinson Disease, Secondary; Phenols; Rats; Rats, Wistar; Rotenone | 2013 |